FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Sep. 17, 2012--
MEDNAX, Inc., (NYSE:MD) today announced the acquisition of Pediatric
Cardiology of Austin, a physician group practice that provides pediatric
cardiology services throughout the central Texas region.
The addition of Pediatric Cardiology of Austin to MEDNAX’s Pediatrix
Medical Group division brings four cardiologists and 10 other clinical
and administrative staff members to the national group practice. The
practice is affiliated with 11 hospitals within the Seton Medical System
and St. David’s Medical System throughout Austin and surrounding
counties, including Dell Children’s Medical Center. Both the Pediatrix
and American Anesthesiology divisions of MEDNAX are already established
providers of specialty services in the Austin area.
Pediatric Cardiology of Austin was established in 2001 by Ronald
Shapiro, M.D. and provides a full spectrum of inpatient and outpatient
services including consultations, echocardiography, fetal
echocardiography, interventional cardiac catheterizations, treatment of
adult congenital heart disease, and pre- and post-operative care for
cardiac surgery.
“Our practice’s core values of quality care, customer service and
patient satisfaction, are very much aligned with those of Pediatrix
Medical Group,” said Ronald Shapiro, M.D., founder and president of
Pediatric Cardiology of Austin, “We look forward to being a part of this
leading national medical group and collaborating with more than 100
pediatric cardiologists throughout the country. This partnership not
only supports our growth prospects but also our infrastructure, and will
in turn, benefit our patients within the community.”
The physicians and employees joining as a result of this transaction
will now be part of MEDNAX’s Pediatrix Medical Group, a national group
practice consisting of the nation’s leading neonatal, maternal-fetal
medicine, pediatric cardiology, and other pediatric specialty physicians.
The practice was acquired for cash and the transaction is expected to be
immediately accretive to earnings. No additional terms of the
transaction were disclosed.
With this acquisition, five physician group practices have become part
of Pediatrix Medical Group and five group practices have become part of
American Anesthesiology in 2012.
ABOUT MEDNAX
MEDNAX, Inc. is a national medical group that comprises the nation's
leading provider of neonatal, maternal-fetal and pediatric physician
subspecialty services as well as anesthesia services. Physicians and
advanced practitioners practicing as part of MEDNAX are reshaping the
delivery of care within their specialties and subspecialties, using
evidence-based tools, continuous quality initiatives and clinical
research to enhance patient outcomes and provide high-quality,
cost-effective care. Pediatrix Medical Group, a unit of MEDNAX, was
founded in 1979 and now includes neonatal physicians who provide
services at more than 300 neonatal intensive care units, who collaborate
with affiliated maternal-fetal medicine, pediatric cardiology and
pediatric critical care physician subspecialists to provide a clinical
care continuum. Pediatrix is also the nation's largest provider of
newborn hearing screens. In 2007, MEDNAX expanded into anesthesia
services. Today, American Anesthesiology includes more than 1,200
anesthesiologists and advanced practitioners who provide anesthesia care
to patients in connection with surgical and other procedures as well as
pain management. MEDNAX, through its affiliated professional
corporations, employs more than 1,900 physicians in 34 states and Puerto
Rico. Additional information is available at www.mednax.com.
Certain statements and information in this press release may be
deemed to contain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995, Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended. Forward-looking statements may
include, but are not limited to, statements relating to our objectives,
plans and strategies, and all statements, other than statements of
historical facts, that address activities, events or developments that
we intend, expect, project, believe or anticipate will or may occur in
the future. These statements are often characterized by terminology such
as “believe”, “hope”, “may”, “anticipate”, “should”, “intend”, “plan”,
“will”, “expect”, “estimate”, “project”, “positioned”, “strategy” and
similar expressions, and are based on assumptions and assessments made
by MEDNAX’s management in light of their experience and their perception
of historical trends, current conditions, expected future developments
and other factors they believe to be appropriate. Any forward-looking
statements in this press release are made as of the date hereof, and
MEDNAX undertakes no duty to update or revise any such statements,
whether as a result of new information, future events or otherwise.
Forward-looking statements are not guarantees of future performance and
are subject to risks and uncertainties. Important factors that could cause
actual results, developments, and business decisions to differ
materially from forward-looking statements are described in MEDNAX’s
most recent Annual Report on Form 10-K and its Quarterly Reports on Form
10-Q, including the sections entitled “Risk Factors”, as well MEDNAX’s
current reports on Form 8-K, filed with the Securities and
Exchange Commission.
Source: MEDNAX, Inc.
MEDNAX, Inc.
David Parker, 954-384-0175, Ext. 5300
Vice
President, Corporate Communications and Investor Relations
david_parker@mednax.com